schliessen

Filtern

 

Bibliotheken

18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial

The use of non-invasive imaging to identify ruptured or high-risk coronary atherosclerotic plaques would represent a major clinical advance for prevention and treatment of coronary artery disease. We used combined PET and CT to identify ruptured and high-risk atherosclerotic plaques using the radioa... Full description

Journal Title: The Lancet 2014, Vol.383 (9918), p.705-713
Main Author: Joshi, Nikhil V
Other Authors: Vesey, Alex T , Williams, Michelle C , Shah, Anoop S V , Calvert, Patrick A , Craighead, Felicity H M , Yeoh, Su Ern , Wallace, William , Salter, Donald , Fletcher, Alison M , van Beek, Edwin J R , Flapan, Andrew D , Uren, Neal G , Behan, Miles W H , Cruden, Nicholas L M , Mills, Nicholas L , Fox, Keith A A , Rudd, James H F , Dweck, Marc R , Newby, David E
Format: Electronic Article Electronic Article
Language: English
Subjects:
Quelle: Alma/SFX Local Collection
Publisher: Kidlington: Elsevier Ltd
ID: ISSN: 0140-6736
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: cdi_proquest_miscellaneous_1505338039
title: 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial
format: Article
creator:
  • Joshi, Nikhil V
  • Vesey, Alex T
  • Williams, Michelle C
  • Shah, Anoop S V
  • Calvert, Patrick A
  • Craighead, Felicity H M
  • Yeoh, Su Ern
  • Wallace, William
  • Salter, Donald
  • Fletcher, Alison M
  • van Beek, Edwin J R
  • Flapan, Andrew D
  • Uren, Neal G
  • Behan, Miles W H
  • Cruden, Nicholas L M
  • Mills, Nicholas L
  • Fox, Keith A A
  • Rudd, James H F
  • Dweck, Marc R
  • Newby, David E
subjects:
  • Aged
  • Angina pectoris
  • Angina Pectoris - metabolism
  • Atherosclerosis (general aspects, experimental research)
  • Biological and medical sciences
  • Blood and lymphatic vessels
  • Cardiology
  • Cardiology. Vascular system
  • Carotid Stenosis - diagnosis
  • Carotid Stenosis - metabolism
  • computed tomography
  • Confounding Factors, Epidemiologic
  • Coronary Angiography
  • coronary artery disease
  • Coronary Artery Disease - diagnosis
  • Coronary Artery Disease - metabolism
  • Coronary vessels
  • Female
  • Fluorodeoxyglucose F18 - metabolism
  • General aspects
  • Heart attacks
  • Humans
  • Male
  • Medical imaging
  • Medical sciences
  • Medicine(all)
  • Middle Aged
  • Myocardial Infarction - metabolism
  • myocardial perfusion
  • Plaque, Atherosclerotic - diagnosis
  • Plaque, Atherosclerotic - metabolism
  • positron emission tomography
  • Positron-Emission Tomography - methods
  • Prospective Studies
  • radiation dose
  • Radiopharmaceuticals - metabolism
  • Risk Factors
  • Rupture, Spontaneous
  • Scotland
  • Sodium Fluoride - metabolism
  • Tomography, X-Ray Computed
ispartof: The Lancet, 2014, Vol.383 (9918), p.705-713
description: The use of non-invasive imaging to identify ruptured or high-risk coronary atherosclerotic plaques would represent a major clinical advance for prevention and treatment of coronary artery disease. We used combined PET and CT to identify ruptured and high-risk atherosclerotic plaques using the radioactive tracers 18F-sodium fluoride (18F-NaF) and 18F-fluorodeoxyglucose (18F-FDG). In this prospective clinical trial, patients with myocardial infarction (n=40) and stable angina (n=40) underwent 18F-NaF and 18F-FDG PET-CT, and invasive coronary angiography. 18F-NaF uptake was compared with histology in carotid endarterectomy specimens from patients with symptomatic carotid disease, and with intravascular ultrasound in patients with stable angina. The primary endpoint was the comparison of 18F-fluoride tissue-to-background ratios of culprit and non-culprit coronary plaques of patients with acute myocardial infarction. In 37 (93%) patients with myocardial infarction, the highest coronary 18F-NaF uptake was seen in the culprit plaque (median maximum tissue-to-background ratio: culprit 1·66 [IQR 1·40–2·25] vs highest non-culprit 1·24 [1·06–1·38], p
language: eng
source: Alma/SFX Local Collection
identifier: ISSN: 0140-6736
fulltext: fulltext
issn:
  • 0140-6736
  • 1474-547X
url: Link


@attributes
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
RANK2.8311722
LOCALfalse
PrimoNMBib
record
control
sourceidproquest_opena
recordidTN_cdi_proquest_miscellaneous_1505338039
sourceformatXML
sourcesystemPC
sourcerecordid3225131031
originalsourceidFETCH-LOGICAL-15415-7a1634cc0b42d2d7d14fbc5e22e177f3f1c6798198ef0ac0e54ecc2b7b7eddcf3
addsrcrecordideNqNkl9r1TAYxosobk4_ghIQYV5U87ZJ0-qFyHAqDL1QwbuQJm92MnuamqSTfRC_r-k5xyMMhrtJQ_p7Ht4_T1E8BvoCKDQvv1BgtGxE3RxD_bwBwVkp7hSHwAQrORPf7xaHe-SgeBDjBaWUNZTfLw4qVlWs67rD4je0p6UdZh-cQTL56FLwI8G1i9HlS_Jrfx7UtLoi1geSoTE567RKy19vSZinNAc0RI2GrNz5qgwu_iDaZxsVrohKKww-6iGfyWkyDernjPEVUWTK7xPq5C6R6MGN2XUgKTg1PCzuWTVEfLT7HhXfTt99PflQnn1-__Hk7VkJnAEvhYKmZlrTnlWmMsIAs73mWFUIQtjagm5E10LXoqVKU-QMta560Qs0Rtv6qPi09fUTjsoFlFNw61y29MpJM2KSBs08yV9WUgrSUMVsRzvoGTVdV3e1pQAaeKVUnmmTDY-3hrm3pc0k8yA1DoMa0c9RAqe8rlualbdAoa0bUS3o02vohZ_DmCezULSlohZVpviW0nmuMaDdNwNULpmRm8zIJRASarnJjBRZ92TnPvdrNHvV35Bk4NkOUDGvyAY1ahf_cW02As4z9_paAdqlTVBSUG7YlxFvKON26puaeLNVY47LpcMgo3Y4ajR5qzqv0bv_OPwBPXYE6w
sourcetypeOpen Access Repository
isCDItrue
recordtypearticle
pqid1500807372
display
typearticle
title18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial
sourceAlma/SFX Local Collection
creatorJoshi, Nikhil V ; Vesey, Alex T ; Williams, Michelle C ; Shah, Anoop S V ; Calvert, Patrick A ; Craighead, Felicity H M ; Yeoh, Su Ern ; Wallace, William ; Salter, Donald ; Fletcher, Alison M ; van Beek, Edwin J R ; Flapan, Andrew D ; Uren, Neal G ; Behan, Miles W H ; Cruden, Nicholas L M ; Mills, Nicholas L ; Fox, Keith A A ; Rudd, James H F ; Dweck, Marc R ; Newby, David E
creatorcontribJoshi, Nikhil V ; Vesey, Alex T ; Williams, Michelle C ; Shah, Anoop S V ; Calvert, Patrick A ; Craighead, Felicity H M ; Yeoh, Su Ern ; Wallace, William ; Salter, Donald ; Fletcher, Alison M ; van Beek, Edwin J R ; Flapan, Andrew D ; Uren, Neal G ; Behan, Miles W H ; Cruden, Nicholas L M ; Mills, Nicholas L ; Fox, Keith A A ; Rudd, James H F ; Dweck, Marc R ; Newby, David E
descriptionThe use of non-invasive imaging to identify ruptured or high-risk coronary atherosclerotic plaques would represent a major clinical advance for prevention and treatment of coronary artery disease. We used combined PET and CT to identify ruptured and high-risk atherosclerotic plaques using the radioactive tracers 18F-sodium fluoride (18F-NaF) and 18F-fluorodeoxyglucose (18F-FDG). In this prospective clinical trial, patients with myocardial infarction (n=40) and stable angina (n=40) underwent 18F-NaF and 18F-FDG PET-CT, and invasive coronary angiography. 18F-NaF uptake was compared with histology in carotid endarterectomy specimens from patients with symptomatic carotid disease, and with intravascular ultrasound in patients with stable angina. The primary endpoint was the comparison of 18F-fluoride tissue-to-background ratios of culprit and non-culprit coronary plaques of patients with acute myocardial infarction. In 37 (93%) patients with myocardial infarction, the highest coronary 18F-NaF uptake was seen in the culprit plaque (median maximum tissue-to-background ratio: culprit 1·66 [IQR 1·40–2·25] vs highest non-culprit 1·24 [1·06–1·38], p<0·0001). By contrast, coronary 18F-FDG uptake was commonly obscured by myocardial uptake and where discernible, there were no differences between culprit and non-culprit plaques (1·71 [1·40–2·13] vs 1·58 [1·28–2·01], p=0·34). Marked 18F-NaF uptake occurred at the site of all carotid plaque ruptures and was associated with histological evidence of active calcification, macrophage infiltration, apoptosis, and necrosis. 18 (45%) patients with stable angina had plaques with focal 18F-NaF uptake (maximum tissue-to-background ratio 1·90 [IQR 1·61–2·17]) that were associated with more high-risk features on intravascular ultrasound than those without uptake: positive remodelling (remodelling index 1·12 [1·09–1·19] vs 1·01 [0·94–1·06]; p=0·0004), microcalcification (73% vs 21%, p=0·002), and necrotic core (25% [21–29] vs 18% [14–22], p=0·001). 18F-NaF PET-CT is the first non-invasive imaging method to identify and localise ruptured and high-risk coronary plaque. Future studies are needed to establish whether this method can improve the management and treatment of patients with coronary artery disease. Chief Scientist Office Scotland and British Heart Foundation.
identifier
0ISSN: 0140-6736
1EISSN: 1474-547X
2DOI: 10.1016/S0140-6736(13)61754-7
3PMID: 24224999
4CODEN: LANCAO
languageeng
publisherKidlington: Elsevier Ltd
subjectAged ; Angina pectoris ; Angina Pectoris - metabolism ; Atherosclerosis (general aspects, experimental research) ; Biological and medical sciences ; Blood and lymphatic vessels ; Cardiology ; Cardiology. Vascular system ; Carotid Stenosis - diagnosis ; Carotid Stenosis - metabolism ; computed tomography ; Confounding Factors, Epidemiologic ; Coronary Angiography ; coronary artery disease ; Coronary Artery Disease - diagnosis ; Coronary Artery Disease - metabolism ; Coronary vessels ; Female ; Fluorodeoxyglucose F18 - metabolism ; General aspects ; Heart attacks ; Humans ; Male ; Medical imaging ; Medical sciences ; Medicine(all) ; Middle Aged ; Myocardial Infarction - metabolism ; myocardial perfusion ; Plaque, Atherosclerotic - diagnosis ; Plaque, Atherosclerotic - metabolism ; positron emission tomography ; Positron-Emission Tomography - methods ; Prospective Studies ; radiation dose ; Radiopharmaceuticals - metabolism ; Risk Factors ; Rupture, Spontaneous ; Scotland ; Sodium Fluoride - metabolism ; Tomography, X-Ray Computed
ispartofThe Lancet, 2014, Vol.383 (9918), p.705-713
rights
02014 Joshi et al. Open Access article distributed under the terms of CC BY
12015 INIST-CNRS
2Copyright © 2014 Joshi et al. Open Access article distributed under the terms of CC BY. Published by Elsevier Ltd. All rights reserved.
3Copyright Elsevier Limited Feb 22, 2014
lds50peer_reviewed
oafree_for_read
citedbyFETCH-LOGICAL-15415-7a1634cc0b42d2d7d14fbc5e22e177f3f1c6798198ef0ac0e54ecc2b7b7eddcf3
citesFETCH-LOGICAL-15415-7a1634cc0b42d2d7d14fbc5e22e177f3f1c6798198ef0ac0e54ecc2b7b7eddcf3
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
thumbnail$$Usyndetics_thumb_exl
backlink
0$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28175155$$DView record in Pascal Francis
1$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24224999$$D View this record in MEDLINE/PubMed
search
creatorcontrib
0Joshi, Nikhil V
1Vesey, Alex T
2Williams, Michelle C
3Shah, Anoop S V
4Calvert, Patrick A
5Craighead, Felicity H M
6Yeoh, Su Ern
7Wallace, William
8Salter, Donald
9Fletcher, Alison M
10van Beek, Edwin J R
11Flapan, Andrew D
12Uren, Neal G
13Behan, Miles W H
14Cruden, Nicholas L M
15Mills, Nicholas L
16Fox, Keith A A
17Rudd, James H F
18Dweck, Marc R
19Newby, David E
title
018F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial
1The Lancet
addtitleLancet
descriptionThe use of non-invasive imaging to identify ruptured or high-risk coronary atherosclerotic plaques would represent a major clinical advance for prevention and treatment of coronary artery disease. We used combined PET and CT to identify ruptured and high-risk atherosclerotic plaques using the radioactive tracers 18F-sodium fluoride (18F-NaF) and 18F-fluorodeoxyglucose (18F-FDG). In this prospective clinical trial, patients with myocardial infarction (n=40) and stable angina (n=40) underwent 18F-NaF and 18F-FDG PET-CT, and invasive coronary angiography. 18F-NaF uptake was compared with histology in carotid endarterectomy specimens from patients with symptomatic carotid disease, and with intravascular ultrasound in patients with stable angina. The primary endpoint was the comparison of 18F-fluoride tissue-to-background ratios of culprit and non-culprit coronary plaques of patients with acute myocardial infarction. In 37 (93%) patients with myocardial infarction, the highest coronary 18F-NaF uptake was seen in the culprit plaque (median maximum tissue-to-background ratio: culprit 1·66 [IQR 1·40–2·25] vs highest non-culprit 1·24 [1·06–1·38], p<0·0001). By contrast, coronary 18F-FDG uptake was commonly obscured by myocardial uptake and where discernible, there were no differences between culprit and non-culprit plaques (1·71 [1·40–2·13] vs 1·58 [1·28–2·01], p=0·34). Marked 18F-NaF uptake occurred at the site of all carotid plaque ruptures and was associated with histological evidence of active calcification, macrophage infiltration, apoptosis, and necrosis. 18 (45%) patients with stable angina had plaques with focal 18F-NaF uptake (maximum tissue-to-background ratio 1·90 [IQR 1·61–2·17]) that were associated with more high-risk features on intravascular ultrasound than those without uptake: positive remodelling (remodelling index 1·12 [1·09–1·19] vs 1·01 [0·94–1·06]; p=0·0004), microcalcification (73% vs 21%, p=0·002), and necrotic core (25% [21–29] vs 18% [14–22], p=0·001). 18F-NaF PET-CT is the first non-invasive imaging method to identify and localise ruptured and high-risk coronary plaque. Future studies are needed to establish whether this method can improve the management and treatment of patients with coronary artery disease. Chief Scientist Office Scotland and British Heart Foundation.
subject
0Aged
1Angina pectoris
2Angina Pectoris - metabolism
3Atherosclerosis (general aspects, experimental research)
4Biological and medical sciences
5Blood and lymphatic vessels
6Cardiology
7Cardiology. Vascular system
8Carotid Stenosis - diagnosis
9Carotid Stenosis - metabolism
10computed tomography
11Confounding Factors, Epidemiologic
12Coronary Angiography
13coronary artery disease
14Coronary Artery Disease - diagnosis
15Coronary Artery Disease - metabolism
16Coronary vessels
17Female
18Fluorodeoxyglucose F18 - metabolism
19General aspects
20Heart attacks
21Humans
22Male
23Medical imaging
24Medical sciences
25Medicine(all)
26Middle Aged
27Myocardial Infarction - metabolism
28myocardial perfusion
29Plaque, Atherosclerotic - diagnosis
30Plaque, Atherosclerotic - metabolism
31positron emission tomography
32Positron-Emission Tomography - methods
33Prospective Studies
34radiation dose
35Radiopharmaceuticals - metabolism
36Risk Factors
37Rupture, Spontaneous
38Scotland
39Sodium Fluoride - metabolism
40Tomography, X-Ray Computed
issn
00140-6736
11474-547X
fulltexttrue
rsrctypearticle
creationdate2014
recordtypearticle
recordideNqNkl9r1TAYxosobk4_ghIQYV5U87ZJ0-qFyHAqDL1QwbuQJm92MnuamqSTfRC_r-k5xyMMhrtJQ_p7Ht4_T1E8BvoCKDQvv1BgtGxE3RxD_bwBwVkp7hSHwAQrORPf7xaHe-SgeBDjBaWUNZTfLw4qVlWs67rD4je0p6UdZh-cQTL56FLwI8G1i9HlS_Jrfx7UtLoi1geSoTE567RKy19vSZinNAc0RI2GrNz5qgwu_iDaZxsVrohKKww-6iGfyWkyDernjPEVUWTK7xPq5C6R6MGN2XUgKTg1PCzuWTVEfLT7HhXfTt99PflQnn1-__Hk7VkJnAEvhYKmZlrTnlWmMsIAs73mWFUIQtjagm5E10LXoqVKU-QMta560Qs0Rtv6qPi09fUTjsoFlFNw61y29MpJM2KSBs08yV9WUgrSUMVsRzvoGTVdV3e1pQAaeKVUnmmTDY-3hrm3pc0k8yA1DoMa0c9RAqe8rlualbdAoa0bUS3o02vohZ_DmCezULSlohZVpviW0nmuMaDdNwNULpmRm8zIJRASarnJjBRZ92TnPvdrNHvV35Bk4NkOUDGvyAY1ahf_cW02As4z9_paAdqlTVBSUG7YlxFvKON26puaeLNVY47LpcMgo3Y4ajR5qzqv0bv_OPwBPXYE6w
startdate20140222
enddate20140222
creator
0Joshi, Nikhil V
1Vesey, Alex T
2Williams, Michelle C
3Shah, Anoop S V
4Calvert, Patrick A
5Craighead, Felicity H M
6Yeoh, Su Ern
7Wallace, William
8Salter, Donald
9Fletcher, Alison M
10van Beek, Edwin J R
11Flapan, Andrew D
12Uren, Neal G
13Behan, Miles W H
14Cruden, Nicholas L M
15Mills, Nicholas L
16Fox, Keith A A
17Rudd, James H F
18Dweck, Marc R
19Newby, David E
general
0Elsevier Ltd
1Elsevier
2Elsevier Limited
3Elsevier BV
scope
06I.
1AAFTH
2IQODW
3CGR
4CUY
5CVF
6ECM
7EIF
8NPM
9AAYXX
10CITATION
110TT
120TZ
130U~
143V.
157QL
167QP
177RV
187TK
197U7
207U9
217X7
227XB
2388A
2488C
2588E
2688G
2788I
288AF
298AO
308C1
318C2
328FE
338FH
348FI
358FJ
368FK
378G5
38ABUWG
39AN0
40ASE
41AZQEC
42BBNVY
43BEC
44BENPR
45BHPHI
46C1K
47DWQXO
48FPQ
49FYUFA
50GHDGH
51GNUQQ
52GUQSH
53H94
54HCIFZ
55K6X
56K9-
57K9.
58KB0
59KB~
60LK8
61M0R
62M0S
63M0T
64M1P
65M2M
66M2O
67M2P
68M7N
69M7P
70MBDVC
71NAPCQ
72PQEST
73PQQKQ
74PQUKI
75Q9U
76S0X
777X8
787U1
797U2
80BOBZL
81CLFQK
sort
creationdate20140222
title18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial
authorJoshi, Nikhil V ; Vesey, Alex T ; Williams, Michelle C ; Shah, Anoop S V ; Calvert, Patrick A ; Craighead, Felicity H M ; Yeoh, Su Ern ; Wallace, William ; Salter, Donald ; Fletcher, Alison M ; van Beek, Edwin J R ; Flapan, Andrew D ; Uren, Neal G ; Behan, Miles W H ; Cruden, Nicholas L M ; Mills, Nicholas L ; Fox, Keith A A ; Rudd, James H F ; Dweck, Marc R ; Newby, David E
facets
frbrtype5
frbrgroupidcdi_FETCH-LOGICAL-15415-7a1634cc0b42d2d7d14fbc5e22e177f3f1c6798198ef0ac0e54ecc2b7b7eddcf3
rsrctypearticles
prefilterarticles
languageeng
creationdate2014
topic
0Aged
1Angina pectoris
2Angina Pectoris - metabolism
3Atherosclerosis (general aspects, experimental research)
4Biological and medical sciences
5Blood and lymphatic vessels
6Cardiology
7Cardiology. Vascular system
8Carotid Stenosis - diagnosis
9Carotid Stenosis - metabolism
10computed tomography
11Confounding Factors, Epidemiologic
12Coronary Angiography
13coronary artery disease
14Coronary Artery Disease - diagnosis
15Coronary Artery Disease - metabolism
16Coronary vessels
17Female
18Fluorodeoxyglucose F18 - metabolism
19General aspects
20Heart attacks
21Humans
22Male
23Medical imaging
24Medical sciences
25Medicine(all)
26Middle Aged
27Myocardial Infarction - metabolism
28myocardial perfusion
29Plaque, Atherosclerotic - diagnosis
30Plaque, Atherosclerotic - metabolism
31positron emission tomography
32Positron-Emission Tomography - methods
33Prospective Studies
34radiation dose
35Radiopharmaceuticals - metabolism
36Risk Factors
37Rupture, Spontaneous
38Scotland
39Sodium Fluoride - metabolism
40Tomography, X-Ray Computed
toplevel
0peer_reviewed
1online_resources
creatorcontrib
0Joshi, Nikhil V
1Vesey, Alex T
2Williams, Michelle C
3Shah, Anoop S V
4Calvert, Patrick A
5Craighead, Felicity H M
6Yeoh, Su Ern
7Wallace, William
8Salter, Donald
9Fletcher, Alison M
10van Beek, Edwin J R
11Flapan, Andrew D
12Uren, Neal G
13Behan, Miles W H
14Cruden, Nicholas L M
15Mills, Nicholas L
16Fox, Keith A A
17Rudd, James H F
18Dweck, Marc R
19Newby, David E
collection
0ScienceDirect Open Access Titles
1Elsevier:ScienceDirect:Open Access
2Pascal-Francis
3Medline
4MEDLINE
5MEDLINE (Ovid)
6MEDLINE
7MEDLINE
8PubMed
9CrossRef
10News PRO
11Pharma and Biotech Premium PRO
12Global News & ABI/Inform Professional
13ProQuest Central (Corporate)
14Bacteriology Abstracts (Microbiology B)
15Calcium & Calcified Tissue Abstracts
16Nursing & Allied Health Database
17Neurosciences Abstracts
18Toxicology Abstracts
19Virology and AIDS Abstracts
20Health & Medical Collection
21ProQuest Central (purchase pre-March 2016)
22Biology Database (Alumni Edition)
23Healthcare Administration Database (Alumni)
24Medical Database (Alumni Edition)
25Psychology Database (Alumni)
26Science Database (Alumni Edition)
27STEM Database
28ProQuest Pharma Collection
29Public Health Database
30Lancet Titles
31ProQuest SciTech Collection
32ProQuest Natural Science Collection
33Hospital Premium Collection
34Hospital Premium Collection (Alumni Edition)
35ProQuest Central (Alumni) (purchase pre-March 2016)
36Research Library (Alumni Edition)
37ProQuest Central (Alumni Edition)
38British Nursing Database
39British Nursing Index
40ProQuest Central Essentials
41Biological Science Collection
42eLibrary
43ProQuest Central
44Natural Science Collection
45Environmental Sciences and Pollution Management
46ProQuest Central Korea
47British Nursing Index (BNI) (1985 to Present)
48Health Research Premium Collection
49Health Research Premium Collection (Alumni)
50ProQuest Central Student
51Research Library Prep
52AIDS and Cancer Research Abstracts
53SciTech Premium Collection
54British Nursing Index
55Consumer Health Database (Alumni Edition)
56ProQuest Health & Medical Complete (Alumni)
57Nursing & Allied Health Database (Alumni Edition)
58ProQuest Newsstand Professional
59ProQuest Biological Science Collection
60Consumer Health Database
61Health & Medical Collection (Alumni Edition)
62Healthcare Administration Database
63Medical Database
64Psychology Database
65Research Library
66Science Database
67Algology Mycology and Protozoology Abstracts (Microbiology C)
68Biological Science Database
69Research Library (Corporate)
70Nursing & Allied Health Premium
71ProQuest One Academic Eastern Edition
72ProQuest One Academic
73ProQuest One Academic UKI Edition
74ProQuest Central Basic
75SIRS Editorial
76MEDLINE - Academic
77Risk Abstracts
78Safety Science and Risk
79OpenAIRE (Open Access)
80OpenAIRE
jtitleThe Lancet
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
au
0Joshi, Nikhil V
1Vesey, Alex T
2Williams, Michelle C
3Shah, Anoop S V
4Calvert, Patrick A
5Craighead, Felicity H M
6Yeoh, Su Ern
7Wallace, William
8Salter, Donald
9Fletcher, Alison M
10van Beek, Edwin J R
11Flapan, Andrew D
12Uren, Neal G
13Behan, Miles W H
14Cruden, Nicholas L M
15Mills, Nicholas L
16Fox, Keith A A
17Rudd, James H F
18Dweck, Marc R
19Newby, David E
formatjournal
genrearticle
ristypeJOUR
atitle18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial
jtitleThe Lancet
addtitleLancet
date2014-02-22
risdate2014
volume383
issue9918
spage705
epage713
pages705-713
issn0140-6736
eissn1474-547X
codenLANCAO
abstractThe use of non-invasive imaging to identify ruptured or high-risk coronary atherosclerotic plaques would represent a major clinical advance for prevention and treatment of coronary artery disease. We used combined PET and CT to identify ruptured and high-risk atherosclerotic plaques using the radioactive tracers 18F-sodium fluoride (18F-NaF) and 18F-fluorodeoxyglucose (18F-FDG). In this prospective clinical trial, patients with myocardial infarction (n=40) and stable angina (n=40) underwent 18F-NaF and 18F-FDG PET-CT, and invasive coronary angiography. 18F-NaF uptake was compared with histology in carotid endarterectomy specimens from patients with symptomatic carotid disease, and with intravascular ultrasound in patients with stable angina. The primary endpoint was the comparison of 18F-fluoride tissue-to-background ratios of culprit and non-culprit coronary plaques of patients with acute myocardial infarction. In 37 (93%) patients with myocardial infarction, the highest coronary 18F-NaF uptake was seen in the culprit plaque (median maximum tissue-to-background ratio: culprit 1·66 [IQR 1·40–2·25] vs highest non-culprit 1·24 [1·06–1·38], p<0·0001). By contrast, coronary 18F-FDG uptake was commonly obscured by myocardial uptake and where discernible, there were no differences between culprit and non-culprit plaques (1·71 [1·40–2·13] vs 1·58 [1·28–2·01], p=0·34). Marked 18F-NaF uptake occurred at the site of all carotid plaque ruptures and was associated with histological evidence of active calcification, macrophage infiltration, apoptosis, and necrosis. 18 (45%) patients with stable angina had plaques with focal 18F-NaF uptake (maximum tissue-to-background ratio 1·90 [IQR 1·61–2·17]) that were associated with more high-risk features on intravascular ultrasound than those without uptake: positive remodelling (remodelling index 1·12 [1·09–1·19] vs 1·01 [0·94–1·06]; p=0·0004), microcalcification (73% vs 21%, p=0·002), and necrotic core (25% [21–29] vs 18% [14–22], p=0·001). 18F-NaF PET-CT is the first non-invasive imaging method to identify and localise ruptured and high-risk coronary plaque. Future studies are needed to establish whether this method can improve the management and treatment of patients with coronary artery disease. Chief Scientist Office Scotland and British Heart Foundation.
copKidlington
pubElsevier Ltd
pmid24224999
doi10.1016/S0140-6736(13)61754-7
oafree_for_read